XRHealth Receives Patent to Measure Sway & Conduct Fall Risk Assessment in Virtual Reality & Augmented Reality Therapy

XRHealth, the leader in extended reality and therapeutic telehealth applications, announces today that they received a patent to measure sway and conduct a fall risk assessment using virtual reality and augmented reality therapy.

According to the CDC, one out of five falls results in serious complications like broken bones or head injury. With the new capability, XRHealth can assess the risk of elderly patients’ likelihood of falling, potentially preventing a debilitating injury.

The patent is entitled “Assessing Postural Sway in Virtual Reality or Augmented Reality.” Sway is measured by using a VR/AR platform to measure positional data from a headset or hand sensors. The positional data then determines the center of mass. When the patient enters the virtual/augmented reality environment, it simulates a situation where the user is unbalanced. The data on position and center of mass is then sent to a server to determine if the person poses a risk for falling.

Three million elderly people are sent to emergency rooms each year to treat injuries from falls and 95% of hip fractures are a result of falls. “When treating elderly patients, the ability to measure sway accurately in an AR/VR therapeutic process can potentially prevent falls that can result in long-term disabilities,” said Eran Orr, CEO of XRHealth. “The advantage of using XR to measure sway is that patients can do this from the comfort of their home, during routine extended reality therapy.”

XRHealth has virtual clinics throughout the United States that treat patients remotely with VR/AR-based therapy while they are examined by a licensed XRHealth therapist. The XRHealth platform combines FDA-registered medical applications with advanced data analytics, providing a comprehensive solution for therapists and patients while collecting and analyzing patient interactions with virtual objects in virtual environments.

 

SourceXRHealth
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version